Large Volume Parenteral Market Size, Industry Analyis By(Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP), By Volume(250 ml - 500 ml, 100 ml-250 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml, 2000 ml and More), By Application(Fluid Balance Injections, Nutritious Injections, Therapeutic Injections), By End User(Hospitals, Clinics) & Forecast 2024-2035
- PUBLISHED ON
- 9/1/2022
- NO OF PAGES
- 215
- CATEGORY
- Healthcare & Life Sciences
The global large volume parenteral (LVP) market size was valued at USD 9.5 billion in 2021 and is projected to reach around USD 15.0 billion in 2030 exhibiting a CAGR of 6.0% in the forecasted period. The increasing prevalence of malnutrition, rising natality rate, and increasing premature births worldwide are fuelling the market growth. Apart from this, the increasing consumption of fast food across the world has resulted in growing instances of non-communicable diseases, such as diabetes, hypertension, obesity, and other metabolic disorders. This is positively impelling the adoption of LVPs that are a mixture of dextrose, lipids, amino acids, trace metals, added electrolytes, and vitamins.
The increasing number of surgeries, need for a faster route of drug administration, rising preference for single-dose administration of vaccines and drugs, and rise in local manufacturing are anticipated to fuel the market for LVP. Furthermore, the growing patient pool suffering from chronic disease is one of the major factors in the large volume parenteral market. For instance, in August 2021 Boehringer Ingelheim GmbH stated that around 60 million or above people globally are affected by the chronic, inactivating cardio-renal-metabolic illness called heart failure. Latest therapy substitutes are urgently required as heart failure prevalence keeps escalating. These patients must need an appropriate balance of vital nutrients that aid in maintaining the hydration level, energy, and strength. The parenteral route of administration helps deliver an accurate dose of medicine as most of the drug is straight absorbed in circulation, skipping the gastrointestinal tract. Hence, target disease act as a crucial factor to upsurge market growth throughout the forecast period.
Furthermore, individuals and healthcare authorities are focusing to limit the mortality rate due to early birth and are thus impelling the use of large volume parenteral. For instance, in February 2022, Amneal Pharmaceuticals, Inc. received approval of four generic injectable products. Additionally, continuing developments in health insurance and medical technology can also fuel the pharma industry by eradicating financial and physical barriers to healthcare access, thereby surging market growth.
The market worldwide was distressed by the closures and lockdowns forced. In this scenario most of healthcare, industries faced a raw material scarcity. Industries were shut, and the supply chain was interrupted. However, the development of vaccines and monoclonal antibodies as injectable forms produced a demand for the LVP market. In October 2021, the published article “Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis Can’t Come Fast Enough for Some People” stated that anti–SARS-CoV-2 monoclonal antibodies are commonly derived from either the B cells of individuals who’ve recovered after COVID-19 or from humanized mice. They aim epitopes on the SARS-CoV-2 spike protein. Infused or injected, monoclonal antibodies deliver almost direct, albeit temporary, “passive immunity” no matter the state of the recipient’s immune system. The benefits of injected monoclonal antibodies as therapeutics in helping Covid-19 are predicted to have a considerable impact on the market. Thus, Covid-19 is predicted to have impacted the market significantly.
Type Insights
Soft Bags large volume parenteral segment has generated a revenue share of more than 40% and dominated the global large volume parenteral market in 2021. The rapid growth in the adoption of soft bag has offered a huge growth opportunity to the large volume parenteral brands that has fostered the growth of the segment.
Soft bag Large Volume Parenteral (LVP) is a bendable plastic material that comprises injection fluid. This product can be used to provide hydration, nourishment, and medication. It also offers the required nutrients to prevent malnutrition in patients who are incapable to eat generally or those undergoing surgery or other medical treatments that cause a loss of appetite.
Application Insights
Fluid balance injections is the leading market segment in 2021. Large Volume Parenteral (LVP) is used in fluid balance injections to enhance the amount of fluid intake. LVP helps to achieve hydration at a quicker rate than drinking fluids alone that can be helpful for people who are not feeling well and may need extra liquids.
In therapeutic infusion, large volume parenteral (LVP) is used for the treatment of anaemia, nutritional support during surgery recovery and to treat malnutrition due to chronic diseases such as cancer diseases, etc. In addition, it also helps in preventing dehydration from diarrhoea and vomiting. It assists to control or avoid problems with fluid and electrolytes.
Region Insights
North America leads the large volume parenteral market owing to the presence of major key players, high research expenditure by healthcare sector, technological development in medical devices in this region. The comprehensions on the growing prevalence of chronic diseases in the United States is one of the major factors driving the growth of the market. For instance, according to the Cancer Facts & Figures 2022 data issued by the American Cancer Society, there will be projected 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the US. Additionally, in the Heart Disease Facts published by the Center for Disease Control and Prevention (CDC) in February 2022, it is declared that coronary heart disease is the most common type of heart disease in the US and around 18.2 million adults aged 20 and older have this in the country.
However, large volume parenteral market in the Asia-Pacific and Europe is anticipated to grow during the forecast period owing to the increasing research and development activities, rising investment in the healthcare sector, and growing focus of emerging markets.
Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions policies to gain a competitive edge and expand their product portfolio & business footmark. The ongoing COVID-19 pandemic hindered the healthcare systems globally and driven market players to update products for unexploited prospects. Some of the key players operating in the global large volume parenteral market include:
• Albert David Ltd.
• B. Braun Melsungen AG
• Baxter
• BML Parenteral Drugs
• Fresenius Kabi AG
• Grifols, S.A.
• Pfizer, Inc.
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Co., Ltd.
• Cipla Inc.
• Zydus Group
• ALTHEA
• Other players
Some of the Recent Developments:
• In June 2022, Akums Drugs & Pharmaceuticals Ltd. (India) acquired the strict European Union (EU) GMP approval for two of their manufacturing units in Haridwar. One plant manufactures solid oral dosage forms such as hard gelatin capsules, tablets, powders in sachets, etc. belonging to the general category, and another plant manufactures large volume parenteral and small volume parenteral lines, including ampoules, vials, eyedrops, FFS and for dry powder injections in the penicillin line.
• In May 2022, the government of India revised the Drug Rule 1945 and delivered a notification to add a sub-rule under Rule 75 (3). This sub-rule will instruct submitting an application with the licensing expert in Form 27D to grant or renew a license for manufacturing, selling, or distributing medicinal drugs in a large volume of parenteral, sera and vaccine, and r-DNA derived drugs.
Segments
By Type
• Soft Bag LVP
• Plastic Bag LVP
• Glass Bottle LVP
By Volume
• 250 ml - 500 ml
• 100 ml-250 ml
• 500 ml - 1000 ml
• 1000 ml - 2000 ml
• 2000 ml and More
By Application
• Fluid Balance Injections
• Nutritious Injections
• Therapeutic Injections
By End User
• Hospitals
• Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Key Points:
Define, describe and forecast Large Volume Parenteral product market by type, application, end user and region.
Provide enterprise external environment analysis and PEST analysis.
Provide strategies for company to deal with the impact of COVID-19.
Provide market dynamic analysis, including market driving factors, market development constraints.
Provide market entry strategy analysis for new players or players who are ready to enter the market, including market segment definition, client analysis, distribution model, product messaging and positioning, and price strategy analysis.
Keep up with international market trends and provide analysis of the impact of the COVID-19 epidemic on major regions of the world.
Analyze the market opportunities of stakeholders and provide market leaders with details of the competitive landscape.
Historic Year: 2016-2022
Forecast: 2024-2035
1 Large Volume Parenteral Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Large Volume Parenteral
1.3 Large Volume Parenteral Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Large Volume Parenteral
1.4.2 Applications of Large Volume Parenteral
1.5 Market Exchange Rate
2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source
3 Market Competition Analysis
3.1 China Resources Double-Crane Market Performance Analysis
3.1.1 China Resources Double-Crane Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 China Resources Double-Crane Sales, Value, Price, Gross Margin 2016-2021
3.2 Shandong Lukang Cisen Pharmaceutical Market Performance Analysis
3.2.1 Shandong Lukang Cisen Pharmaceutical Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Shandong Lukang Cisen Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
3.3 Qingzhou Yaowang Medicine Market Performance Analysis
3.3.1 Qingzhou Yaowang Medicine Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Qingzhou Yaowang Medicine Sales, Value, Price, Gross Margin 2016-2021
3.4 Jilin Dubang Pharmaceutical Market Performance Analysis
3.4.1 Jilin Dubang Pharmaceutical Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Jilin Dubang Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
3.5 Kelun Pharma Market Performance Analysis
3.5.1 Kelun Pharma Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Kelun Pharma Sales, Value, Price, Gross Margin 2016-2021
3.6 Lijun International Pharmaceutical (Holding) Market Performance Analysis
3.6.1 Lijun International Pharmaceutical (Holding) Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Lijun International Pharmaceutical (Holding) Sales, Value, Price, Gross Margin 2016-2021
3.7 Jinjian Cereals Market Performance Analysis
3.7.1 Jinjian Cereals Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Jinjian Cereals Sales, Value, Price, Gross Margin 2016-2021
3.8 Southwest Pharmaceutical Market Performance Analysis
3.8.1 Southwest Pharmaceutical Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Southwest Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
3.9 Huaren Pharmaceutical Market Performance Analysis
3.9.1 Huaren Pharmaceutical Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Huaren Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
3.10 Fengyuan Pharmaceutical Market Performance Analysis
3.10.1 Fengyuan Pharmaceutical Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Fengyuan Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
3.11 China Otsuka Pharmaceutical Market Performance Analysis
3.11.1 China Otsuka Pharmaceutical Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 China Otsuka Pharmaceutical Sales, Value, Price, Gross Margin 2016-2021
4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Large Volume Parenteral Production and Value by Type
4.1.1 Global Large Volume Parenteral Production by Type 2016-2021
4.1.2 Global Large Volume Parenteral Market Value by Type 2016-2021
4.2 Global Large Volume Parenteral Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Injection for Body Fluid Balance Market Production, Value and Growth Rate
4.2.2 Therapeutic Injection Market Production, Value and Growth Rate
4.2.3 Nutritious Injection Market Production, Value and Growth Rate
4.2.4 Peritoneal Dialysate Market Production, Value and Growth Rate
4.3 Global Large Volume Parenteral Production and Value Forecast by Type
4.3.1 Global Large Volume Parenteral Production Forecast by Type 2021-2026
4.3.2 Global Large Volume Parenteral Market Value Forecast by Type 2021-2026
4.4 Global Large Volume Parenteral Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 Injection for Body Fluid Balance Market Production, Value and Growth Rate Forecast
4.4.2 Therapeutic Injection Market Production, Value and Growth Rate Forecast
4.4.3 Nutritious Injection Market Production, Value and Growth Rate Forecast
4.4.4 Peritoneal Dialysate Market Production, Value and Growth Rate Forecast
5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Large Volume Parenteral Consumption and Value by Application
5.1.1 Global Large Volume Parenteral Consumption by Application 2016-2021
5.1.2 Global Large Volume Parenteral Market Value by Application 2016-2021
5.2 Global Large Volume Parenteral Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 ＜30 Years Old Market Consumption, Value and Growth Rate
5.2.2 30 Years Old-60 Years Old Market Consumption, Value and Growth Rate
5.2.3 ＞60 Years Old Market Consumption, Value and Growth Rate
5.3 Global Large Volume Parenteral Consumption and Value Forecast by Application
5.3.1 Global Large Volume Parenteral Consumption Forecast by Application 2021-2026
5.3.2 Global Large Volume Parenteral Market Value Forecast by Application 2021-2026
5.4 Global Large Volume Parenteral Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 ＜30 Years Old Market Consumption, Value and Growth Rate Forecast
5.4.2 30 Years Old-60 Years Old Market Consumption, Value and Growth Rate Forecast
5.4.3 ＞60 Years Old Market Consumption, Value and Growth Rate Forecast
6 Global Large Volume Parenteral by Region, Historical Data and Market Forecasts
6.1 Global Large Volume Parenteral Sales by Region 2016-2021
6.2 Global Large Volume Parenteral Market Value by Region 2016-2021
6.3 Global Large Volume Parenteral Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Large Volume Parenteral Sales Forecast by Region 2021-2026
6.5 Global Large Volume Parenteral Market Value Forecast by Region 2021-2026
6.6 Global Large Volume Parenteral Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa
7 United State Market Size Analysis 2016-2026
7.1 United State Large Volume Parenteral Value and Market Growth 2016-2021
7.2 United State Large Volume Parenteral Sales and Market Growth 2016-2021
7.3 United State Large Volume Parenteral Market Value Forecast 2021-2026
8 Canada Market Size Analysis 2016-2026
8.1 Canada Large Volume Parenteral Value and Market Growth 2016-2021
8.2 Canada Large Volume Parenteral Sales and Market Growth 2016-2021
8.3 Canada Large Volume Parenteral Market Value Forecast 2021-2026
9 Germany Market Size Analysis 2016-2026
9.1 Germany Large Volume Parenteral Value and Market Growth 2016-2021
9.2 Germany Large Volume Parenteral Sales and Market Growth 2016-2021
9.3 Germany Large Volume Parenteral Market Value Forecast 2021-2026
10 UK Market Size Analysis 2016-2026
10.1 UK Large Volume Parenteral Value and Market Growth 2016-2021
10.2 UK Large Volume Parenteral Sales and Market Growth 2016-2021
10.3 UK Large Volume Parenteral Market Value Forecast 2021-2026
11 France Market Size Analysis 2016-2026
11.1 France Large Volume Parenteral Value and Market Growth 2016-2021
11.2 France Large Volume Parenteral Sales and Market Growth 2016-2021
11.3 France Large Volume Parenteral Market Value Forecast 2021-2026
12 Italy Market Size Analysis 2016-2026
12.1 Italy Large Volume Parenteral Value and Market Growth 2016-2021
12.2 Italy Large Volume Parenteral Sales and Market Growth 2016-2021
12.3 Italy Large Volume Parenteral Market Value Forecast 2021-2026
13 Spain Market Size Analysis 2016-2026
13.1 Spain Large Volume Parenteral Value and Market Growth 2016-2021
13.2 Spain Large Volume Parenteral Sales and Market Growth 2016-2021
13.3 Spain Large Volume Parenteral Market Value Forecast 2021-2026
14 Russia Market Size Analysis 2016-2026
14.1 Russia Large Volume Parenteral Value and Market Growth 2016-2021
14.2 Russia Large Volume Parenteral Sales and Market Growth 2016-2021
14.3 Russia Large Volume Parenteral Market Value Forecast 2021-2026
15 China Market Size Analysis 2016-2026
15.1 China Large Volume Parenteral Value and Market Growth 2016-2021
15.2 China Large Volume Parenteral Sales and Market Growth 2016-2021
15.3 China Large Volume Parenteral Market Value Forecast 2021-2026
16 Japan Market Size Analysis 2016-2026
16.1 Japan Large Volume Parenteral Value and Market Growth 2016-2021
16.2 Japan Large Volume Parenteral Sales and Market Growth 2016-2021
16.3 Japan Large Volume Parenteral Market Value Forecast 2021-2026
17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Large Volume Parenteral Value and Market Growth 2016-2021
17.2 South Korea Large Volume Parenteral Sales and Market Growth 2016-2021
17.3 South Korea Large Volume Parenteral Market Value Forecast 2021-2026
18 Australia Market Size Analysis 2016-2026
18.1 Australia Large Volume Parenteral Value and Market Growth 2016-2021
18.2 Australia Large Volume Parenteral Sales and Market Growth 2016-2021
18.3 Australia Large Volume Parenteral Market Value Forecast 2021-2026
19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Large Volume Parenteral Value and Market Growth 2016-2021
19.2 Thailand Large Volume Parenteral Sales and Market Growth 2016-2021
19.3 Thailand Large Volume Parenteral Market Value Forecast 2021-2026
20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Large Volume Parenteral Value and Market Growth 2016-2021
20.2 Brazil Large Volume Parenteral Sales and Market Growth 2016-2021
20.3 Brazil Large Volume Parenteral Market Value Forecast 2021-2026
21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Large Volume Parenteral Value and Market Growth 2016-2021
21.2 Argentina Large Volume Parenteral Sales and Market Growth 2016-2021
21.3 Argentina Large Volume Parenteral Market Value Forecast 2021-2026
22 Chile Market Size Analysis 2016-2026
22.1 Chile Large Volume Parenteral Value and Market Growth 2016-2021
22.2 Chile Large Volume Parenteral Sales and Market Growth 2016-2021
22.3 Chile Large Volume Parenteral Market Value Forecast 2021-2026
23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Large Volume Parenteral Value and Market Growth 2016-2021
23.2 South Africa Large Volume Parenteral Sales and Market Growth 2016-2021
23.3 South Africa Large Volume Parenteral Market Value Forecast 2021-2026
24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Large Volume Parenteral Value and Market Growth 2016-2021
24.2 Egypt Large Volume Parenteral Sales and Market Growth 2016-2021
24.3 Egypt Large Volume Parenteral Market Value Forecast 2021-2026
25 UAE Market Size Analysis 2016-2026
25.1 UAE Large Volume Parenteral Value and Market Growth 2016-2021
25.2 UAE Large Volume Parenteral Sales and Market Growth 2016-2021
25.3 UAE Large Volume Parenteral Market Value Forecast 2021-2026
26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Large Volume Parenteral Value and Market Growth 2016-2021
26.2 Saudi Arabia Large Volume Parenteral Sales and Market Growth 2016-2021
26.3 Saudi Arabia Large Volume Parenteral Market Value Forecast 2021-2026
27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI